In summary, we found that NSUN2 acted as an oncogene through promoting gastric cancer development by repressing p57Kip2 in an m5C-dependent manner, which may provide a novel therapeutic target against gastric cancer. The gene discussed is NSUN2; the disease is gastric cancer.